George Rho
Research analyst, long/short equity, special situations, arbitrage

Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher

The subject of this research report is a tiny development-stage biotechnology concern, which means its common stock is, almost by definition, incredibly volatile. Significantly, too, the dual facts that the company's lead new-drug prospect has only completed Phase 2 clinical testing and could be years from commercial viability inject substantial additional uncertainty and risk. That's not all, the results of the two Phase 2 studies haven't even been released yet. Now that all of the prudent investors have been scared off, we highlight here the reasons why we're recommending the shares of Prana Biotechnology Ltd (NASDAQ: PRAN), even if only as an issue worthy of close monitoring. First, an impressive 40 of 42 patients (95.2%) enrolled in one study...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details